US 11672794
Therapeutic targeting of the BAP1 complex in cancer
granted A61KA61K31/423A61K31/473
Quick answer
US patent 11672794 (Therapeutic targeting of the BAP1 complex in cancer) held by Northwestern University expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/423, A61K31/473, A61P, A61P35/02